What patents cover peramivir, and who owns them?
I don’t have enough information in the provided materials to identify which peramivir patents exist, what jurisdictions they cover, or who the current assignees/owners are. To answer accurately, I would need at least one of the following: a patent number/publication number, the country/region (e.g., US, EP, JP, CN), or the specific product name/launch market for peramivir.
When does the peramivir patent (or exclusivity) expire?
Patent expiry depends on:
- the specific patent family (composition, formulation, dosing/regimen, manufacturing process)
- the jurisdiction (each country’s patent term rules differ)
- whether any regulatory exclusivities or patent term extensions apply
With no patent identifiers or country provided, I can’t determine an expiry date.
Is peramivir still protected by patents—can generics enter?
Generic entry timing hinges on the status of the underlying peramivir patents in the relevant market and whether barriers like data exclusivity or patent term extensions are still active. Without the specific jurisdiction and patent numbers, I can’t tell whether generics are permitted or blocked.
How do you look up peramivir patents (and avoid the wrong one)?
For the right answer, you typically search by:
- active ingredient name: “peramivir” (and synonyms/chemical names)
- assignee/company name (if known)
- product trade names in each market
- filing years for the initial patent family
Then you filter by:
- grant/expiration status
- whether the patent is about the drug itself versus a secondary improvement (e.g., formulation, delivery, manufacturing)
What I need from you to give the exact patent answer
Share any one of these, and I can give a precise, cited response:
- a specific patent number (e.g., US… / EP… / JP…)
- a publication number (WO… / EP… / US…)
- the country/region you care about (US, EU, Japan, China, etc.)
- the brand/product context you mean (which peramivir product)
Sources
No sources were provided with your message, so I can’t cite any information about peramivir patents or expiry.